As innovations and discoveries in cancer immunotherapies
progress at lightning speed, it is critical to understand the successes and
challenges with current immunotherapies to separate the hype from the real
opportunities. IBC's Immuno-Oncology event develops tactics for improving the
efficacy and response rates with first generation immunotherapies and builds a
strategy for utilizing combination therapies, t-cell therapies, and checkpoint
inhibitors to propel the next wave of cancer immunotherapies.
Download the Immuno-Oncology brochure now to create your
pathway for an answer to cancer: http://bit.ly/1O6tbIZ
Immuno-Oncology
Advancing the Next Generation of Cancer
Immunotherapies
September 30 – October 1, 2015
Hilton Alexandria Mark Center, Alexandria,
VA
Register today and explore the latest advances in
Immuno-Oncology to:
Develop next generation immunotherapies by understanding
recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors,
cancer vaccines, and agnostic antibodies
Create a successful combination therapy strategy by gaining
insights from global leaders on effective combinations
Optimize the discovery and development of your promising
immunotherapies by hearing best practices and lessons learned from the first
wave of cancer immunotherapies
Download the brochure
for full program details: http://bit.ly/1O6tbIZ
Reserve your seat
now. Use code IMMUNO15BL to get $100 off the current rate. Register today: http://bit.ly/1O6tbIZ
Best,
The Immuno-Oncology Team 2015
@ibcusa
#Immuno15
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment